What one share of Reviva Pharmaceuticals Holdings holds
On December 14, 2020, our predecessor company, formerly known as Tenzing Acquisition Corp., a British Virgin Islands exempted company (“Tenzing”), and Reviva Pharmaceuticals, Inc., a Delaware corporation (together with its consolidated subsidiaries, “Old Reviva”), consummated the transactions (the “Business Combination”) contemplated by the Agreement and Plan of Merger, dated as of July 20, 2020 (as amended, the “Merger Agreement”), by and among Tenzing, Tenzing Merger…
Reviva Pharmaceuticals Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.76 |
|---|---|
| Cash and investments | $1.52 |
| Book value | $1.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | — | −$17.73 | — | — | — | $0.34 |
| 2025 | — | −$5.48 | — | — | — | $1.47 |
Common questions about Reviva Pharmaceuticals Holdings
How much does one share of Reviva Pharmaceuticals Holdings earn?
Over the last 12 months, Reviva Pharmaceuticals Holdings lost $1.76 for each share.
Does Reviva Pharmaceuticals Holdings pay a dividend?
Reviva Pharmaceuticals Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Reviva Pharmaceuticals Holdings’s book value per share?
Reviva Pharmaceuticals Holdings’s book value is $1.16 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Reviva Pharmaceuticals Holdings have?
Each share of Reviva Pharmaceuticals Holdings has $1.52 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.